471 related articles for article (PubMed ID: 12538683)
1. Critical role of MHC class I-related chain A and B expression on IFN-alpha-stimulated dendritic cells in NK cell activation: impairment in chronic hepatitis C virus infection.
Jinushi M; Takehara T; Kanto T; Tatsumi T; Groh V; Spies T; Miyagi T; Suzuki T; Sasaki Y; Hayashi N
J Immunol; 2003 Feb; 170(3):1249-56. PubMed ID: 12538683
[TBL] [Abstract][Full Text] [Related]
2. Autocrine/paracrine IL-15 that is required for type I IFN-mediated dendritic cell expression of MHC class I-related chain A and B is impaired in hepatitis C virus infection.
Jinushi M; Takehara T; Tatsumi T; Kanto T; Groh V; Spies T; Suzuki T; Miyagi T; Hayashi N
J Immunol; 2003 Nov; 171(10):5423-9. PubMed ID: 14607946
[TBL] [Abstract][Full Text] [Related]
3. Negative regulation of NK cell activities by inhibitory receptor CD94/NKG2A leads to altered NK cell-induced modulation of dendritic cell functions in chronic hepatitis C virus infection.
Jinushi M; Takehara T; Tatsumi T; Kanto T; Miyagi T; Suzuki T; Kanazawa Y; Hiramatsu N; Hayashi N
J Immunol; 2004 Nov; 173(10):6072-81. PubMed ID: 15528343
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of human cord blood CD34+ cell-derived NK cell cytotoxicity by dendritic cells.
Yu Y; Hagihara M; Ando K; Gansuvd B; Matsuzawa H; Tsuchiya T; Ueda Y; Inoue H; Hotta T; Kato S
J Immunol; 2001 Feb; 166(3):1590-600. PubMed ID: 11160200
[TBL] [Abstract][Full Text] [Related]
5. The reciprocal interaction of NK cells with plasmacytoid or myeloid dendritic cells profoundly affects innate resistance functions.
Gerosa F; Gobbi A; Zorzi P; Burg S; Briere F; Carra G; Trinchieri G
J Immunol; 2005 Jan; 174(2):727-34. PubMed ID: 15634892
[TBL] [Abstract][Full Text] [Related]
6. HLA class I molecules regulate IFN-gamma production induced in NK cells by target cells, viral products, or immature dendritic cells through the inhibitory receptor ILT2/CD85j.
Morel E; Bellón T
J Immunol; 2008 Aug; 181(4):2368-81. PubMed ID: 18684926
[TBL] [Abstract][Full Text] [Related]
7. Engagement of TLR3, TLR7, and NKG2D regulate IFN-gamma secretion but not NKG2D-mediated cytotoxicity by human NK cells stimulated with suboptimal doses of IL-12.
Girart MV; Fuertes MB; Domaica CI; Rossi LE; Zwirner NW
J Immunol; 2007 Sep; 179(6):3472-9. PubMed ID: 17804388
[TBL] [Abstract][Full Text] [Related]
8. Role of cross-talk between IFN-alpha-induced monocyte-derived dendritic cells and NK cells in priming CD8+ T cell responses against human tumor antigens.
Tosi D; Valenti R; Cova A; Sovena G; Huber V; Pilla L; Arienti F; Belardelli F; Parmiani G; Rivoltini L
J Immunol; 2004 May; 172(9):5363-70. PubMed ID: 15100276
[TBL] [Abstract][Full Text] [Related]
9. Reciprocal activating interaction between 6-sulfo LacNAc+ dendritic cells and NK cells.
Wehner R; Löbel B; Bornhäuser M; Schäkel K; Cartellieri M; Bachmann M; Rieber EP; Schmitz M
Int J Cancer; 2009 Jan; 124(2):358-66. PubMed ID: 18942710
[TBL] [Abstract][Full Text] [Related]
10. IFN-alpha skews monocyte differentiation into Toll-like receptor 7-expressing dendritic cells with potent functional activities.
Mohty M; Vialle-Castellano A; Nunes JA; Isnardon D; Olive D; Gaugler B
J Immunol; 2003 Oct; 171(7):3385-93. PubMed ID: 14500632
[TBL] [Abstract][Full Text] [Related]
11. Soluble HLA-G molecules impair natural killer/dendritic cell crosstalk via inhibition of dendritic cells.
Gros F; Cabillic F; Toutirais O; Maux AL; Sebti Y; Amiot L
Eur J Immunol; 2008 Mar; 38(3):742-9. PubMed ID: 18266268
[TBL] [Abstract][Full Text] [Related]
12. Reciprocal activating interaction between natural killer cells and dendritic cells.
Gerosa F; Baldani-Guerra B; Nisii C; Marchesini V; Carra G; Trinchieri G
J Exp Med; 2002 Feb; 195(3):327-33. PubMed ID: 11828007
[TBL] [Abstract][Full Text] [Related]
13. Helper activity of natural killer cells during the dendritic cell-mediated induction of melanoma-specific cytotoxic T cells.
Wong JL; Mailliard RB; Moschos SJ; Edington H; Lotze MT; Kirkwood JM; Kalinski P
J Immunother; 2011 Apr; 34(3):270-8. PubMed ID: 21389871
[TBL] [Abstract][Full Text] [Related]
14. Rapid generation of potent and tumor-specific cytotoxic T lymphocytes by interleukin 18 using dendritic cells and natural killer cells.
Tanaka F; Hashimoto W; Okamura H; Robbins PD; Lotze MT; Tahara H
Cancer Res; 2000 Sep; 60(17):4838-44. PubMed ID: 10987295
[TBL] [Abstract][Full Text] [Related]
15. Dendritic cells and NK cells stimulate bystander T cell activation in response to TLR agonists through secretion of IFN-alpha beta and IFN-gamma.
Kamath AT; Sheasby CE; Tough DF
J Immunol; 2005 Jan; 174(2):767-76. PubMed ID: 15634897
[TBL] [Abstract][Full Text] [Related]
16. Dendritic cells mediate NK cell help for Th1 and CTL responses: two-signal requirement for the induction of NK cell helper function.
Mailliard RB; Son YI; Redlinger R; Coates PT; Giermasz A; Morel PA; Storkus WJ; Kalinski P
J Immunol; 2003 Sep; 171(5):2366-73. PubMed ID: 12928383
[TBL] [Abstract][Full Text] [Related]
17. Transglutaminase 2 on the surface of dendritic cells is proposed to be involved in dendritic cell-T cell interaction.
Kim JH; Jeong EM; Jeong YJ; Lee WJ; Kang JS; Kim IG; Hwang YI
Cell Immunol; 2014; 289(1-2):55-62. PubMed ID: 24727157
[TBL] [Abstract][Full Text] [Related]
18. Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells.
Ferlazzo G; Tsang ML; Moretta L; Melioli G; Steinman RM; Münz C
J Exp Med; 2002 Feb; 195(3):343-51. PubMed ID: 11828009
[TBL] [Abstract][Full Text] [Related]
19. Regulatory Dendritic Cells Restrain NK Cell IFN-γ Production through Mechanisms Involving NKp46, IL-10, and MHC Class I-Specific Inhibitory Receptors.
Spallanzani RG; Torres NI; Avila DE; Ziblat A; Iraolagoitia XL; Rossi LE; Domaica CI; Fuertes MB; Rabinovich GA; Zwirner NW
J Immunol; 2015 Sep; 195(5):2141-8. PubMed ID: 26232426
[TBL] [Abstract][Full Text] [Related]
20. NKp46 and NKG2D recognition of infected dendritic cells is necessary for NK cell activation in the human response to influenza infection.
Draghi M; Pashine A; Sanjanwala B; Gendzekhadze K; Cantoni C; Cosman D; Moretta A; Valiante NM; Parham P
J Immunol; 2007 Mar; 178(5):2688-98. PubMed ID: 17312110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
